Kidney Biopsy Market Research Report– Global Forecast till 2027

Kidney Biopsy Market Research Report: By Type (Percutaneous and Surgical Biopsy), Indication (Hematuria, Kidney Failure, Proteinuria, Kidney Transplant), End User (Hospitals & Clinics, Tertiary Care Centers, Urology Centers) – Global Forecast till 2027

ID: MRFR/MED/3867-HCR | | Region: Global | 110 pages

Market Scenario 


Kidney biopsy, also known as renal biopsy is a procedure for obtaining a sample from kidney tissue for analysis. Kidney biopsy is used to diagnose kidney disease, monitor the effect of treatment, and determine whether the kidney transplant is working well or not. It consists of mainly two types; percutaneous biopsy and surgical biopsy. In a percutaneous biopsy, a needle is inserted into the kidney through the skin, while in the surgical biopsy, an incision is made in the skin near the kidney to take a tissue sample for examination.


As per the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), kidney disease is often referred to as a “silent disease” as there are no symptoms in its early stages and can go undetected. Chronic kidney disease (CKD) is a global health burden and a risk factor for cardiovascular disease (CVD). High blood pressure and diabetes are the main causes of CKD.


Increasing number of biopsy procedures and rising demand for new techniques for diagnosis of chronic diseases are the major drivers for the growth of the market. Additionally, increasing prevalence of kidney diseases and rising need for the better diagnostic and treatment methods drive the growth of the market. Established market players in the developed countries lead the globalization by offering new products and services to the developing countries and emerging economies. However, the high cost of diagnostic services may hinder the market growth during the forecast period.


The global kidney biopsy market is expected to grow at a CAGR of ~5.2% during the forecast period, 2017-2023.

Research Methodology Kidney Biopsy Market


Intended Audience



  • Research and Development (R&D) Companies

  • Ambulatory Care Centers

  • Academic Institutes and Universities

  • Biotechnology Companies

  • Medical Device Manufacturers

  • Medical Device Suppliers

  • Market Research and Consulting Service Providers

  • Potential Investors 


Key Players


Boston Scientific Corporation (U.S.), Cook Medical (U.S.), C R Bard, Inc. (U.S.), Devicor Medical Products Inc. (U.S.), Hologic Inc. (U.S.), Intact Medical Corporation (U.S.), Precision Biopsy, LLC (U.S.), Scion Medical Technologies LLC (U.S.), Integra LifeSciences Corporation (U.S.), Creganna (U.S.), Focal Therapeutics, Inc. (U.S.), CareFusion (U.S.), Argon Medical Devices, Inc. (U.S.) and others.


Figure: Global Kidney Biopsy Market, By Region Market Share, 2016 (%) Global Kidney Biopsy Market


Sources: Annual reports, Press release, White paper, Company presentation


Segmentations


The global kidney biopsy market is segmented on the basis of type, indication, and end user.


On the basis of diagnosis, it is segmented into percutaneous biopsy and surgical biopsy.


On the basis of indication, it is segmented into hematuria, kidney failure, proteinuria, kidney transplant, and others.


Based on the end user, it is segmented into hospitals & clinics, tertiary care centers, urology centers, and others.


Regional Analysis


Globally, the market exhibits high growth potential. NIDDK also stated that the overall prevalence of Chronic Kidney Disease (CKD) in the general population is approximately 14%. It also stated that in 2013, Medicare expenditure for patients with CKD aged 65 and older exceeded USD 50 billion which accounted for 20% of all Medicare spending in this age group. More than 70% of Medicare spending for CKD patients aged 65 and older was incurred by those who also had diabetes or congestive heart failure.


In the Americas, the market is driven by the extensive use of technologically advanced medical devices for diagnosis and treatment of kidney disease, government support for research & development, and high health care spending. Additionally, increasing patient population with kidney disease, diabetes, and other risk factors for renal failure is fuelling the market growth


Europe is the second largest market for kidney biopsy whose growth is attributed to an increasing emphasis on the development of new diagnostic devices in urology, rising government support for research & development, and availability of funds for research. Rising number of specialty services offered by various healthcare providers in Europe also accelerate the growth of the market. Furthermore, favorable reimbursement policies, increased application and significant investments in the development of new technologies for the treatment of diseases will fuel the market growth during the forecast period.


Asia Pacific is the fastest growing kidney biopsy market owing to the ever-increasing prevalence of diabetes, and rising number of kidney transplant procedures in urology centers. Rapidly developing healthcare technology sector and high healthcare expenditure also drive the market. Furthermore, increasing demand for quality devices in the healthcare is expected to lead the use of advanced equipment, which, in turn, may speed up the market growth in this region.    


However, the Middle East & Africa holds the least share of the kidney biopsy market due to less availability of funds, limited medical facilities, and unavailability of technologically advanced medical devices. In the Middle East, the United Arab Emirates (U.A.E) is the largest market owing to the progress of healthcare industry.




Frequently Asked Questions (FAQ) :


The kidney biopsy market would grow with 5.2% during the forecast period.

High cost of diagnostic tools can deter the kidney biopsy market.

The end users in the kidney biopsy market are tertiary care centers, urology centers, hospitals & clinics, and others.

The dominating kidney biospy market region is the Americas.

The second-largest kidney biopsy market is Europe.

Table Of Content


Report Prologue

Market Introduction


2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations


Research Methodology


3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation


Market Dynamics


4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment


Market Factor Analysis


5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis


Global Kidney Biopsy Market, By Type


6.1 Introduction

6.2 Percutaneous Biopsy

6.2.1 Market Estimates & Forecast, 2020 – 2027

6.3 Surgical Biopsy

6.3.1 Market Estimates & Forecast, 2020 – 2027 7. Global Kidney Biopsy Market, By Indication

7.1 Introduction

7.2 Hematuria

7.2.1 Market Estimates & Forecast, 2020 – 2027

7.3 Kidney Failure

7.3.1 Market Estimates & Forecast, 2020 – 2027

7.4 Proteinuria

7.4.1 Market Estimates & Forecast, 2020 – 2027

7.5 Kidney Transplant

7.5.1 Market Estimates & Forecast, 2020 – 2027

7.6 Others

7.6.1 Market Estimates & Forecast, 2020 – 2027


Global Kidney Biopsy Market, By End User


8.1 Introduction

8.2 Hospitals & Clinics

8.2.1 Market Estimates & Forecast, 2020 – 2027

8.3 Tertiary Care Centers

8.3.1 Market Estimates & Forecast, 2020 – 2027

8.4 Urology Centers

8.4.1 Market Estimates & Forecast, 2020 – 2027

8.5 Others

8.5.1 Market Estimates & Forecast, 2020 – 2027


Global Kidney Biopsy Market, By Region


9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 U.K

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest Of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic Of Korea

9.4.6 Rest Of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest Of The Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 Cook Medical

11.1.1 Company Overview

11.1.2 Indication Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Boston Scientific Corporation

11.2.1 Company Overview

11.2.2 Indication Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Hologic Inc.

11.3.1 Company Overview

11.3.2 Indication Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Devicor Medical Products Inc.

11.4.1 Company Overview

11.4.2 Indication/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 C. R. Bard, Inc.

11.5.1 Company Overview

11.5.2 Indication Overview

11.5.3 Financial Overview

11.5.4 Key Developments

11.6 Intact Medical Corporation

11.6.1 Overview

11.6.2 Indication Overview

11.6.3 Financials

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Precision Biopsy, LLC

11.7.1 Overview

11.7.2 Indication Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Scion Medical Technologies LLC

11.8.1 Overview

11.8.2 Indication Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs Of The Market

12.2 Key Companies To Watch

12.3 Prediction Of Medical Device Industry

13 Appendix

LIST OF TABLES

Table 1 Kidney Biopsy Industry Synopsis, 2020 – 2027

Table 2 Global Kidney Biopsy Market Estimates And Forecast, 2020 – 2027, (USD Million)

Table 3 Global Kidney Biopsy Market By Region, 2020 – 2027, (USD Million)

Table 4 Global Kidney Biopsy Market By Types, 2020 – 2027, (USD Million)

Table 5 Global Kidney Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 7 Global Kidney Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 8 North America Kidney Biopsy Market By Types, 2020 – 2027, (USD Million)

Table 9 North America Kidney Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 11 North America Kidney Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 12 U.S. Kidney Biopsy Market By Types, 2020 – 2027, (USD Million)

Table 13 U.S. Kidney Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 15 U.S. Kidney Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 16 Canada Kidney Biopsy Market By Types, 2020 – 2027, (USD Million)

Table 17 Canada Kidney Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 19 Canada Kidney Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 20 South America Kidney Biopsy Market By Types, 2020 – 2027, (USD Million)

Table 21 South America Kidney Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 23 South America Kidney Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 24 Europe Kidney Biopsy Market By Types, 2020 – 2027, (USD Million)

Table 25 Europe Kidney Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 27 Europe Kidney Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 28 Western Europe Kidney Biopsy Market By Types, 2020 – 2027, (USD Million)

Table 29 Western Europe Kidney Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 31 Western Europe Kidney Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 32 Eastern Europe Kidney Biopsy Market By Types, 2020 – 2027, (USD Million)

Table 33 Eastern Europe Kidney Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 35 Eastern Europe Kidney Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 36 Asia Pacific Kidney Biopsy Market By Types, 2020 – 2027, (USD Million)

Table 37 Asia Pacific Kidney Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 39 Asia Pacific Kidney Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 40 Middle East & Africa Kidney Biopsy Market By Types, 2020 – 2027, (USD Million)

Table 41 Middle East & Africa Kidney Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 43 Middle East & Africa Kidney Biopsy Market By End Users, 2020 – 2027, (USD Million) LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Kidney Biopsy Market

Figure 3 Segmentation Market Dynamics For Kidney Biopsy Market

Figure 4 Global Kidney Biopsy Market Share, By Type, 2020

Figure 5 Global Kidney Biopsy Market Share, By Indication, 2020

Figure 6 Global Kidney Biopsy Market Share, By End Users, 2020

Figure 7 Global Kidney Biopsy Market Share, By Region, 2020

Figure 8 North America Kidney Biopsy Market Share, By Country, 2020

Figure 9 Europe Kidney Biopsy Market Share, By Country, 2020

Figure 10 Asia Pacific Kidney Biopsy Market Share, By Country, 2020

Figure 11 Middle East & Africa Kidney Biopsy Market Share, By Country, 2020

Figure 12 Global Kidney Biopsy Market: Company Share Analysis, 2020 (%)

Figure 13 Cook Medical: Key Financials

Figure 14 Cook Medical: Segmental Revenue

Figure 16 Cook Medical: Geographical Revenue

Figure 17 Boston Scientific Corporation: Key Financials

Figure 18 Boston Scientific Corporation: Segmental Revenue

Figure 19 Boston Scientific Corporation: Geographical Revenue

Figure 20 Hologic Inc.: Key Financials

Figure 21 Hologic Inc.: Segmental Revenue

Figure 22 Hologic Inc.: Geographical Revenue

Figure 23 Devicor Medical Products Inc.: Key Financials

Figure 24 Devicor Medical Products Inc.: Segmental Revenue

Figure 25 Devicor Medical Products Inc.: Geographical Revenue

Figure 26 Scion Medical Technologies LLC: Key Financials

Figure 27 Scion Medical Technologies LLC: Segmental Revenue

Figure 28 Scion Medical Technologies LLC: Geographical Revenue

Figure 29 C. R. Bard, Inc.: Key Financials

Figure 30 C. R. Bard, Inc.: Segmental Revenue

Figure 31 C. R. Bard, Inc.: Geographical Revenue

Figure 32 Intact Medical Corporation: Key Financials

Figure 33 Intact Medical Corporation: Segmental Revenue

Figure 34 Intact Medical Corporation: Geographical Revenue

Bottom of Form